Alabama's First Medical Cannabis Dispensary Opens After 5 Years

Five Years in the Making

When Alabama lawmakers passed the Darren Wesley "Ato" Hall Compassionate Use Act in May 2021, they joined a growing list of conservative Southern states cautiously embracing medical cannabis. What followed was anything but cautious: nearly five years of legal battles, licensing disputes, commission controversies, and bureaucratic delays that made Alabama's medical cannabis rollout one of the most protracted in American history.

Now, finally, the finish line is in sight. Callie's Apothecary, located in Montgomery, is expected to become the first medical cannabis dispensary in Alabama history when it opens its doors in May 2026.

The Long Road to Opening Day

The Alabama Medical Cannabis Commission (AMCC) was tasked with overseeing the program's implementation, including the licensing of cultivators, processors, transporters, and dispensaries. From the start, the process was dogged by problems.

The commission's initial licensing round in 2022 was challenged in court by applicants who alleged procedural irregularities. Multiple lawsuits followed, with judges issuing injunctions that froze the licensing process for months at a time. The commission voted to rescind and reissue licenses, only to face additional legal challenges from the new round of decisions.

By 2024, the situation had become so tangled that some observers questioned whether the program would ever get off the ground. Patients who qualified under the law — those with conditions including cancer, chronic pain, epilepsy, and PTSD — waited with growing frustration as the legal machinery ground on.

Callie's Apothecary: First to the Finish

CCS of Alabama LLC, operating under the name Callie's Apothecary, emerged from the licensing gauntlet with approval to open dispensary locations. The Montgomery location is expected to be the first to serve patients, with additional sites planned in Bessemer and Talladega.

The dispensary's opening represents more than a business milestone — it is a proof of concept for medical cannabis in one of the most conservative states in the country. Alabama's program is among the most restrictive in the nation, with a limited list of qualifying conditions, no allowance for smokable flower (patients can access tablets, capsules, tinctures, patches, suppositories, nebulizers, and gels), and strict limits on THC content.

The Broader Dispensary Landscape

Callie's Apothecary may be first, but it will not be alone for long. The AMCC has cleared a judicial pathway to issue three of the four dispensary-only licenses to businesses authorized to operate up to three retail facilities each. That means as many as nine dispensaries could open in the coming months, with a tenth possible pending the outcome of litigation over the fourth license.

The commission has also licensed cultivators and processors, meaning the supply chain necessary to stock dispensary shelves is being assembled in parallel. Alabama-grown medical cannabis products could be available to patients by late spring or early summer 2026.

What Patients Can Access

Alabama's medical cannabis program covers a specific list of qualifying conditions, including autism spectrum disorder, cancer, Crohn's disease, depression, epilepsy, HIV/AIDS, panic disorder, Parkinson's disease, persistent nausea, PTSD, sickle cell anemia, spasticity associated with spinal cord injuries, Tourette's syndrome, and several others.

Notably absent from the approved product list is smokable cannabis flower — a restriction that sets Alabama apart from many other medical cannabis states. Patients will instead access cannabis through processed forms: tablets, capsules, tinctures, topical patches, suppositories, nebulizers, and gelatinous cubes. Each product will have defined THC limits and will be dispensed based on a physician's recommendation.

Costs and Access Concerns

One concern that patient advocates have raised is cost. Medical cannabis programs in states with limited competition and extensive regulatory requirements tend to produce higher-priced products. With only a handful of dispensaries serving the entire state initially, Alabama patients may face both high prices and limited geographic access — particularly those in rural areas far from Montgomery, Bessemer, or Talladega.

The state has not implemented a reciprocity program with other states' medical cannabis cards, meaning Alabama's program is strictly for Alabama residents with Alabama-issued recommendations.

A Southern Shift

Alabama's entry into the medical cannabis market, however belated, is part of a broader shift across the Deep South. Mississippi launched its medical cannabis program in 2024. Louisiana has had a medical program since 2016, though it has struggled with limited patient enrollment and high costs. Florida's medical cannabis market, by contrast, has become one of the largest in the country.

The Southern states that have embraced medical cannabis have generally done so with extensive restrictions — no smokable flower, limited qualifying conditions, tight THC caps — reflecting the political realities of conservative legislatures. Alabama fits that pattern precisely.

What Happens Next

For the estimated thousands of Alabama residents who could qualify for medical cannabis, the opening of Callie's Apothecary marks the end of a long wait and the beginning of a new chapter. The practical questions — Can they find a recommending physician? Can they afford the products? Will supply meet demand? — will be answered in the weeks and months following the first dispensary's opening.

For the broader cannabis industry, Alabama's journey offers a case study in how not to roll out a medical cannabis program: the legal challenges, licensing controversies, and multi-year delays have cost patients access and cost the state tax revenue. As other states consider medical cannabis legislation, Alabama's experience is a cautionary tale about the importance of clear regulatory frameworks — in contrast to states like Illinois, which invested $31.8M in equity programs to support new operators, transparent licensing processes, and realistic implementation timelines.

But for now, the story is a simple one: after nearly five years of waiting, Alabama patients are about to have legal access to medical cannabis for the first time. It took far longer than anyone expected. It is finally happening.